U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054606) titled 'A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear' on June 27.
Brief Summary: Assess the impact of concomitant Miebo use while wearing contact lenses
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Dry Eye
Intervention:
DRUG: Perfluorohexyloctane ophthalmic solution
Eligible subjects will receive Miebo up to 4 times bilaterally on Day 1/Visit 1 (1 drop instilled bilaterally by site staff in-clinic while wearing contact lenses and the rest self-administered throughout the remainder of the day while wearing contact lenses). Starting on Day 2, subjects will self-administer the firs...